Picosecond Laser system
DevicePicosecond Laser System for the Treatment of Unwanted Tattoos
NCT Number: NCT02146807
The purpose of this study is to determine whether Pico laser is effective and safe in the treatment of unwanted tattoos.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Washington Institute of Dermatologic Laser Surgery, Washington D.C., District of Columbia, United States
The Investigational device is a dual wavelength laser system developed for treatment of pigmented lesions and for tattoo removal. The base unit is a GentleMax Pro laser system modified to emit light at wavelengths of 532 and 1064 nm and deliver pulse energy up to 400mJ, and pulse duration of 700 ps.
A multicenter study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Picosecond Laser System for the Treatment of Unwanted Tattoos
Time frame: 3 months post the final treatment
Global percentage of tattoo clearance evaluated by blinded observers using post treatment photographs compared to baseline photographs.
Time frame: 3 months
The average number of treatments will be determined in order to obtain 50% and 75% tattoo clearance. Rate of clearance will be assessed globally independent of tattoo color and based on individual colors.
Time frame: 3 months
Adverse events will be evaluated immediately after and before each subsequent laser treatment and will be based on the incidence and severity of side effects caused by the laser treatments.
Syneron Medical
Industry
LASER TREATMENT OF TATTOOS WITH A DUAL WAVELENGTH PICOSECOND LASER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02103153
Unwanted Tattoos
New York, United States
View Trial DetailsNCT02110121
Unwanted Tattoos
Westford, Massachusetts, United States
View Trial DetailsNCT02110095
Unwanted Tattoos
Chestnut Hill, Massachusetts, United States
View Trial Details